Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?

Experimental Cell Research

Volumn 316, Issue 8, 2010, Pages 1365-1373

  Gleissman, Helena ^a   Johnsen, John Inge ^a   Kogner, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; Docosahexaenoic acid; Docosanoids; Eicosanoids; Omega 3 fatty acids; Polyunsaturated fatty acids

Indexed keywords

CD59 ANTIGEN; CELL PROTEIN; CISPLATIN; CURCUMIN; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; DOCOSAHEXAENOIC ACID; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; IRINOTECAN; MELPHALAN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN E2; RESOLVIN; UNCLASSIFIED DRUG; VINCRISTINE;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CANCER RESEARCH; CANCER THERAPY; CELL PROTECTION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG CYTOTOXICITY; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; FATTY ACID ANALYSIS; HUMAN; LOW DRUG DOSE; NEUROBLASTOMA; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; ANIMAL; NEOPLASM;

ANIMALIA;

ANIMALS; FATTY ACIDS, OMEGA-3; HUMANS; NEOPLASMS;

EID: 77952580135     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.02.039     Document Type: Review

References (77)

1. Krishnamoorthy S., Honn K.V. Eicosanoids in tumor progression and metastasis. Subcell. Biochem. 2008, 49:145-168.
2. Koki A.T., Masferrer J.L. Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 2002, 9:28-35.
3. Hull M.A., Ko S.C., Hawcroft G. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?. Mol. Cancer Ther. 2004, 3:1031-1039.
4. Massoumi R., Sjolander A. The role of leukotriene receptor signaling in inflammation and cancer. ScientificWorldJournal 2007, 7:1413-1421.
5. Kokoglu E., Tuter Y., Yazici Z., Sandikci K.S., Sonmez H., Ulakoglu E.Z., Ozyurt E. Profiles of the fatty acids in the plasma membrane of human brain tumors. Cancer Biochem. Biophys. 1998, 16:301-312.
6. Martin D.D., Robbins M.E., Spector A.A., Wen B.C., Hussey D.H. The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue. Lipids 1996, 31:1283-1288.
7. Reynolds L.M., Dalton C.F., Reynolds G.P. Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 2001, 309:193-196.
8. Marugame T., Kamo K., Katanoda K., Ajiki W., Sobue T. Cancer incidence and incidence rates in Japan in 2000: Estimates based on data from 11 population-based cancer registries. Jpn. J. Clin. Oncol. 2006, 36:668-675.
9. Courtney E.D., Matthews S., Finlayson C., Di Pierro D., Belluzzi A., Roda E., Kang J.Y., Leicester R.J. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int. J. Colorectal Dis. 2007, 22:765-776.
10. Fradet V., Cheng I., Casey G., Witte J.S. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin. Cancer Res. 2009, 15:2559-2566.
11. Smith-Warner S.A., Spiegelman D., Ritz J., Albanes D., Beeson W.L., Bernstein L., Berrino F., van den Brandt P.A., Buring J.E., Cho E., Colditz G.A., Folsom A.R., Freudenheim J.L., Giovannucci E., Goldbohm R.A., Graham S., Harnack L., Horn-Ross P.L., Krogh V., Leitzmann M.F., McCullough M.L., Miller A.B., Rodriguez C., Rohan T.E., Schatzkin A., Shore R., Virtanen M., Willett W.C., Wolk A., Zeleniuch-Jacquotte A., Zhang S.M., Hunter D.J. Methods for pooling results of epidemiologic studies: the pooling project of prospective studies of diet and cancer. Am. J. Epidemiol. 2006, 163:1053-1064.
12. Thiebaut A.C., Chajes V., Gerber M., Boutron-Ruault M.C., Joulin V., Lenoir G., Berrino F., Riboli E., Benichou J., Clavel-Chapelon F. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int. J. Cancer 2009, 124:924-931.
13. Wolk A., Larsson S.C., Johansson J.E., Ekman P. Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA 2006, 296:1371-1376.
14. E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, R.G. Holzer, C.H. Osterreicher, H. Takahashi, M. Karin, Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell 140 197-208.
15. Bang H.O., Dyerberg J., Nielsen A.B. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 1971, 1:1143-1145.
16. Riediger N.D., Othman R.A., Suh M., Moghadasian M.H. A systemic review of the roles of n-3 fatty acids in health and disease. J. Am. Diet. Assoc. 2009, 109:668-679.
17. Pauwels E.K., Kairemo K. Fatty acid facts, part II: role in the prevention of carcinogenesis, or, more fish on the dish?. Drug News Perspect 2008, 21:504-510.
18. Tapiero H., Ba G.N., Couvreur P., Tew K.D. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed. Pharmacother. 2002, 56:215-222.
19. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., Moussignac R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-1037.
20. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
21. Voss A., Reinhart M., Sankarappa S., Sprecher H. The metabolism of 7, 10, 13, 16, 19-docosapentaenoic acid to 4, 7, 10, 13, 16, 19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 1991, 266:19995-20000.
22. Piomelli D., Astarita G., Rapaka R. A neuroscientist's guide to lipidomics. Nat Rev Neurosci 2007, 8:743-754.
23. Gani O.A., Sylte I. Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha. J Mol Graph Model 2008, 27:217-224.
24. Zapata-Gonzalez F., Rueda F., Petriz J., Domingo P., Villarroya F., Diaz-Delfin J., de Madariaga M.A., Domingo J.C. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J Leukoc Biol 2008, 84:1172-1182.
25. de Urquiza A.M., Liu S., Sjoberg M., Zetterstrom R.H., Griffiths W., Sjovall J., Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290:2140-2144.
26. Lengqvist J., Mata De Urquiza A., Bergman A.C., Willson T.M., Sjovall J., Perlmann T., Griffiths W.J. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol Cell Proteomics 2004, 3:692-703.
27. Berquin I.M., Edwards I.J., Chen Y.Q. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 2008, 269:363-377.
28. Sun H., Berquin I.M., Owens R.T., O'Flaherty J.T., Edwards I.J. Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res. 2008, 68:2912-2919.
29. Zand H., Rhimipour A., Bakhshayesh M., Shafiee M., Nour Mohammadi I., Salimi S. Involvement of PPAR-gamma and p53 in DHA-induced apoptosis in Reh cells. Mol. Cell. Biochem. 2007, 304:71-77.
30. Jude S., Roger S., Martel E., Besson P., Richard S., Bougnoux P., Champeroux P., Le Guennec J.Y. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog. Biophys. Mol. Biol. 2006, 90:299-325.
31. Gleissman H., Yang R., Martinod K., Lindskog M., Serhan C.N., Johnsen J.I., Kogner P. Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. FASEB J. 2010, 24:906-915.
32. Sveinbjornsson B., Rasmuson A., Baryawno N., Wan M., Pettersen I., Ponthan F., Orrego A., Haeggstrom J.Z., Johnsen J.I., Kogner P. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. FASEB J. 2008, 22:3525-3536.
33. Akihisa T., Tokuda H., Ogata M., Ukiya M., Iizuka M., Suzuki T., Metori K., Shimizu N., Nishino H. Cancer chemopreventive effects of polyunsaturated fatty acids. Cancer Lett. 2004, 205:9-13.
34. Manna S., Chakraborty T., Ghosh B., Chatterjee M., Panda A., Srivastava S., Rana A. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7, 12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:5-14.
35. Noguchi M., Minami M., Yagasaki R., Kinoshita K., Earashi M., Kitagawa H., Taniya T., Miyazaki I. Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. Br. J. Cancer 1997, 75:348-353.
36. Yuri T., Danbara N., Tsujita-Kyutoku M., Fukunaga K., Takada H., Inoue Y., Hada T., Tsubura A. Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr. Cancer 2003, 45:211-217.
37. Toriyama-Baba H., Iigo M., Asamoto M., Iwahori Y., Park C.B., Han B.S., Takasuka N., Kakizoe T., Ishikawa C., Yazawa K., Araki E., Tsuda H. Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model. Jpn J Cancer Res 2001, 92:1175-1183.
38. Takahashi M., Minamoto T., Yamashita N., Yazawa K., Sugimura T., Esumi H. Reduction in formation and growth of 1, 2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid. Cancer Res. 1993, 53:2786-2789.
39. Iigo M., Nakagawa T., Ishikawa C., Iwahori Y., Asamoto M., Yazawa K., Araki E., Tsuda H. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br. J. Cancer 1997, 75:650-655.
40. Ramos E.J., Middleton F.A., Laviano A., Sato T., Romanova I., Das U.N., Chen C., Qi Y., Meguid M.M. Effects of omega-3 fatty acid supplementation on tumor-bearing rats. J Am Coll Surg 2004, 199:716-723.
41. Kelavkar U.P., Hutzley J., Dhir R., Kim P., Allen K.G., McHugh K. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 2006, 8:112-124.
42. Kang J.X., Wang J., Wu L., Kang Z.B. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427:504.
43. Xia S., Lu Y., Wang J., He C., Hong S., Serhan C.N., Kang J.X. Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proc Natl Acad Sci U S A 2006, 103:12499-12504.
44. Jia Q., Lupton J.R., Smith R., Weeks B.R., Callaway E., Davidson L.A., Kim W., Fan Y.Y., Yang P., Newman R.A., Kang J.X., McMurray D.N., Chapkin R.S. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res. 2008, 68:3985-3991.
45. Lu Y., Nie D., Witt W.T., Chen Q., Shen M., Xie H., Lai L., Dai Y., Zhang J. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation. Mol Cancer Ther 2008, 7:3203-3211.
46. Lanier A.P., Holck P., Ehrsam Day G., Key C. Childhood cancer among Alaska Natives. Pediatrics 2003, 112:e396.
47. Lucas M., Dewailly E., Muckle G., Ayotte P., Bruneau S., Gingras S., Rhainds M., Holub B.J. Gestational age and birth weight in relation to n-3 fatty acids among Inuit. Lipids 2004, 39:617-626.
48. Swamy M.V., Citineni B., Patlolla J.M., Mohammed A., Zhang Y., Rao C.V. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr. Cancer 2008, 60(Suppl 1):81-89.
49. Bougnoux P., Hajjaji N., Ferrasson M.N., Giraudeau B., Couet C., Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br. J. Cancer 2009, 101:1978-1985.
50. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83:1467S-1476S.
51. Childs C.E., Romeu-Nadal M., Burdge G.C., Calder P.C. Gender differences in the n-3 fatty acid content of tissues. Proc. Nutr. Soc. 2008, 67:19-27.
52. Rusca A., Di Stefano A.F., Doig M.V., Scarsi C., Perucca E. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers. Eur. J. Clin. Pharmacol. 2009.
53. Lindskog M., Gleissman H., Ponthan F., Castro J., Kogner P., Johnsen J.I. Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress. Int. J. Cancer 2006, 118:2584-2593.
54. Serini S., Piccioni E., Merendino N., Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 2009, 14:135-152.
55. Calviello G., Di Nicuolo F., Serini S., Piccioni E., Boninsegna A., Maggiano N., Ranelletti F.O., Palozza P. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil. Cancer Chemother. Pharmacol. 2005, 55:12-20.
56. Danbara N., Yuri T., Tsujita-Kyutoku M., Sato M., Senzaki H., Takada H., Hada T., Miyazawa T., Okazaki K., Tsubura A. Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of colo 201 human colon cancer cells. Nutr. Cancer 2004, 50:71-79.
57. Yamagami T., Porada C.D., Pardini R.S., Zanjani E.D., Almeida-Porada G. Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line. Cancer Biol Ther 2009, 8:331-337.
58. Arita K., Kobuchi H., Utsumi T., Takehara Y., Akiyama J., Horton A.A., Utsumi K. Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. Biochem. Pharmacol. 2001, 62:821-828.
59. Biondo P.D., Brindley D.N., Sawyer M.B., Field C.J. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 2008, 19:787-796.
60. LeBlanc C.J., Horohov D.W., Bauer J.E., Hosgood G., Mauldin G.E. Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs. Am. J. Vet. Res. 2008, 69:486-493.
61. Lim K., Han C., Xu L., Isse K., Demetris A.J., Wu T. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res. 2008, 68:553-560.
62. Warstedt K., Furuhjelm C., Duchen K., Falth-Magnusson K., Fageras M. The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine and chemokine secretion. Pediatr. Res. 2009, 66:212-217.
63. Baryawno N., Sveinbjornsson B., Eksborg S., Orrego A., Segerstrom L., Oqvist C.O., Holm S., Gustavsson B., Kagedal B., Kogner P., Johnsen J.I. Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets. Neuro Oncol 2008, 10:661-674.
64. Johnsen J.I., Lindskog M., Ponthan F., Pettersen I., Elfman L., Orrego A., Sveinbjornsson B., Kogner P. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo. Cancer Res. 2004, 64:7210-7215.
65. Ponthan F., Wickstrom M., Gleissman H., Fuskevag O.M., Segerstrom L., Sveinbjornsson B., Redfern C.P., Eksborg S., Kogner P., Johnsen J.I. Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo. Clin Cancer Res 2007, 13:1036-1044.
66. Narayanan N.K., Narayanan B.A., Reddy B.S. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors. Int J Oncol 2005, 26:785-792.
67. Chiu L.C., Tong K.F., Ooi V.E. Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells. Biomed. Pharmacother. 2005, 59(Suppl 2):S293-S297.
68. Narayanan N.K., Narayanan B.A., Bosland M., Condon M.S., Nargi D. Docosahexaenoic acid in combination with celecoxib modulates HSP70 and p53 proteins in prostate cancer cells. Int. J. Cancer 2006, 119:1586-1598.
69. Larsson S.C., Kumlin M., Ingelman-Sundberg M., Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 2004, 79:935-945.
70. Siddiqui R.A., Harvey K., Stillwell W. Anticancer properties of oxidation products of docosahexaenoic acid. Chem. Phys. Lipids 2008, 153:47-56.
71. Liu X., Shibata T., Hisaka S., Kawai Y., Osawa T. DHA hydroperoxides as a potential inducer of neuronal cell death: a mitochondrial dysfunction-mediated pathway. J Clin Biochem Nutr 2008, 43:26-33.
72. Yi L., Zhang Q.Y., Mi M.T. Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid. Ai Zheng 2007, 26:1281-1286.
73. Goua M., Mulgrew S., Frank J., Rees D., Sneddon A.A., Wahle K.W. Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-kappaB?. Prostaglandins Leukot. Essent. Fatty Acids 2008, 78:33-43.
74. Schaefer M.B., Wenzel A., Fischer T., Braun-Dullaeus R.C., Renner F., Dietrich H., Schaefer C.A., Seeger W., Mayer K. Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: impact on adhesion and apoptosis. Atherosclerosis 2008, 197:630-637.
75. Rose D.P., Connolly J.M. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int J Oncol 1999, 15:1011-1015.
76. Victory R., Saed G.M., Diamond M.P. Antiadhesion effects of docosahexaenoic acid on normal human peritoneal and adhesion fibroblasts. Fertil. Steril. 2007, 88:1657-1662.
77. Spencer L., Mann C., Metcalfe M., Webb M., Pollard C., Spencer D., Berry D., Steward W., Dennison A. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur. J. Cancer 2009, 45:2077-2086.